|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.844
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.793
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.785
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.547
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.524
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.452
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.427
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.410
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.401
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.396
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.389
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.354
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.339
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.321
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.293
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.293
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.288
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.271
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.243
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.241
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.241
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.232
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.228
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.214
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.190
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.187
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.184
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.181
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.180
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.176
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.172
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.170
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.168
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.164
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.158
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.156
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.156
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.154
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.146
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.140
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.132
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.132
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.128
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.127
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.126
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.126
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.124
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.122
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.121
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.121
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.120
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.120
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.116
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.116
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.115
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.114
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.111
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.111
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.111
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.110
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.104
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.102
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.097
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.096
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.095
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.094
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.093
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.093
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.092
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.091
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.091
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.091
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.090
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.089
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.088
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.086
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.086
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.086
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.085
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.084
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.084
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.082
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.082
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.080
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.079
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.079
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.079
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.078
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.078
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.078
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.076
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.075
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.075
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.074
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.074
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.073
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.072
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.072
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.070
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.070
|
|
|
|
negative regulation of cell proliferation involved in contact inhibition
|
GO:0060244 |
3 |
0.070
|
|
|
|
positive regulation of organic acid transport
|
GO:0032892 |
11 |
0.069
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.068
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.068
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.067
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.067
|
|
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.066
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.066
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.065
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.063
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.063
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.063
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.062
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.061
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.061
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.061
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.060
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.060
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.059
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.059
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.059
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.059
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.059
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.058
|
|
|
|
cellular response to prostaglandin d stimulus
|
GO:0071799 |
1 |
0.057
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.057
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.057
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.056
|
|
|
|
negative regulation of lipase activity
|
GO:0060192 |
7 |
0.056
|
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.055
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.055
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.054
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.053
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.053
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.053
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.053
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.052
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.052
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.052
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.052
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.051
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.051
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.051
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.051
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.051
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.051
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.051
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.051
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.051
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.050
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.050
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.048
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.048
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.047
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.046
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.046
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.046
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.046
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.046
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.045
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.045
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.045
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.045
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.045
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.045
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.044
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.044
|
|
|
|
positive regulation of tendon cell differentiation
|
GO:2001051 |
1 |
0.044
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.043
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.043
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.042
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.042
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.041
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.041
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.041
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.041
|
|
|
|
negative regulation of fatty acid transport
|
GO:2000192 |
1 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.041
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.040
|
|
|
|
tendon development
|
GO:0035989 |
6 |
0.040
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.040
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.040
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.039
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.039
|
|
|
|
negative regulation of phospholipase a2 activity
|
GO:1900138 |
1 |
0.039
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.038
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.038
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.038
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.038
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.038
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.037
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.037
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.037
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.037
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.037
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.037
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.036
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.036
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.036
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.036
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.036
|
|
|
|
regulation of macrophage migration inhibitory factor signaling pathway
|
GO:2000446 |
1 |
0.036
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.036
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.036
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.035
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.035
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.035
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.035
|
|
|
|
regulation of cardiac muscle hypertrophy
|
GO:0010611 |
13 |
0.035
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.035
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.034
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.034
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.034
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.034
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.034
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.034
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.033
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.033
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.033
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.033
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.033
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.033
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.032
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.032
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.032
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.032
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.032
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.032
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.032
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.032
|
|
|
|
contact inhibition
|
GO:0060242 |
3 |
0.031
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.031
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.031
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.031
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.031
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.030
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.030
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.030
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.029
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.029
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.029
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.029
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.029
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.029
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.028
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.028
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.028
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.028
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.028
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.028
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.028
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.028
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.028
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.028
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.028
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.028
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.027
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.027
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.027
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.027
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.027
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.027
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.027
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.026
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.026
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.026
|
|
|
|
positive regulation of receptor activity
|
GO:2000273 |
17 |
0.026
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.026
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.025
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.025
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.025
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.025
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.025
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.025
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.025
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.025
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.025
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.024
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.024
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.024
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.024
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.024
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.024
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.024
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.023
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.023
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.023
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.023
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.023
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902219 |
1 |
0.023
|
|
|
|
negative regulation of erk1 and erk2 cascade
|
GO:0070373 |
21 |
0.023
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.022
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.022
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.022
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.022
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
|
branching involved in prostate gland morphogenesis
|
GO:0060442 |
15 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.022
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.022
|
|
|
|
inhibition of neuroepithelial cell differentiation
|
GO:0002085 |
2 |
0.021
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.021
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.021
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.020
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.020
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.020
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.020
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.020
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.020
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.020
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.020
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.020
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.020
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.020
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.020
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.020
|
|
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
23 |
0.020
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.019
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
18 |
0.019
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.019
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.019
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.019
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.019
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.019
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.019
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.019
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.019
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.019
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.019
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.018
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
|
regulation of arachidonic acid secretion
|
GO:0090237 |
4 |
0.018
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.018
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.018
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.018
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.018
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.018
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.018
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.018
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.018
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.018
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.018
|
|
|
|
regulation of muscle hypertrophy
|
GO:0014743 |
13 |
0.018
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.018
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.017
|
|
|
|
response to prostaglandin d
|
GO:0071798 |
1 |
0.017
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.017
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.017
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.017
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.017
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.017
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.017
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.017
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.017
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.017
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.016
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.016
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.016
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.016
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.016
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.016
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.016
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.016
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.016
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.016
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.016
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.016
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.016
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.016
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.016
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.016
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.016
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.016
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.016
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.016
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.015
|
|
|
|
inositol phosphate mediated signaling
|
GO:0048016 |
13 |
0.015
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.015
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.015
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.015
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.015
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.015
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.015
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.015
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.015
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.015
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.015
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.014
|
|
|
|
dermatome development
|
GO:0061054 |
1 |
0.014
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.014
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.014
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.014
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.014
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.014
|
|
|
|
cellular response to prostaglandin e stimulus
|
GO:0071380 |
1 |
0.014
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.014
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.014
|
|
|
|
otic vesicle development
|
GO:0071599 |
14 |
0.014
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.014
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.014
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.014
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.014
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.014
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.014
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.014
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.014
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.014
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.014
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.014
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.013
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.013
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.013
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.013
|
|
|
|
protein localization to synapse
|
GO:0035418 |
11 |
0.013
|
|
|
|
limb bud formation
|
GO:0060174 |
10 |
0.013
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.013
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.013
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.013
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
|
regulation of anion transport
|
GO:0044070 |
27 |
0.013
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.013
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.013
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.013
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.013
|
|
|
|
exploration behavior
|
GO:0035640 |
21 |
0.013
|
|